Index RUT
P/E -
EPS (ttm) -3.92
Insider Own 37.98%
Shs Outstand 97.87M
Perf Week -8.59%
Market Cap 415.92M
Forward P/E -
EPS next Y -4.76
Insider Trans -0.10%
Shs Float 61.35M
Perf Month -36.86%
Income -381.64M
PEG -
EPS next Q -0.96
Inst Own 72.81%
Short Float 12.79%
Perf Quarter -44.23%
Sales 0.00M
P/S -
EPS this Y 24.27%
Inst Trans -
Short Ratio 6.36
Perf Half Y -55.55%
Book/sh 6.71
P/B 0.63
EPS next Y -15.86%
ROA -
Short Interest 7.85M
Perf Year -
Cash/sh 7.29
P/C 0.58
EPS next 5Y -
ROE -
52W Range 4.18 - 29.88
Perf YTD -43.63%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -58.04%
52W High -85.93%
Beta -
Dividend TTM -
Quick Ratio 8.65
Sales past 5Y 0.00%
Gross Margin -
52W Low 0.60%
ATR (14) 0.37
Dividend Ex-Date -
Current Ratio 8.65
EPS Y/Y TTM -
Oper. Margin 0.00%
RSI (14) 20.43
Volatility 6.61% 6.44%
Employees 130
Debt/Eq 0.00
Sales Y/Y TTM -
Profit Margin -
Recom 1.40
Target Price 31.00
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q -526.06%
Payout -
Rel Volume 0.61
Prev Close 4.24
Sales Surprise -
EPS Surprise 551.50%
Sales Q/Q -
Earnings Mar 28 AMC
Avg Volume 1.23M
Price 4.20
SMA20 -21.21%
SMA50 -38.31%
SMA200 -63.31%
Trades
Volume 744,279
Change -0.83%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-13-23 Initiated
Wells Fargo
Equal Weight
$11
Dec-08-23 Initiated
Citigroup
Neutral
$8
Sep-13-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$19
Sep-05-23 Initiated
H.C. Wainwright
Buy
$44
May-30-23 Initiated
TD Cowen
Outperform
May-30-23 Initiated
Piper Sandler
Overweight
$68
May-30-23 Initiated
Morgan Stanley
Overweight
May-30-23 Initiated
Jefferies
Buy
$31
Apr-29-24 04:05PM
Mar-28-24 10:53PM
04:05PM
Mar-27-24 04:01PM
Mar-21-24 11:12AM
07:00AM
Loading…
Mar-20-24 07:00AM
12:39AM
Mar-11-24 10:04AM
(FierceBiotech.com) +10.96%
08:02AM
08:00AM
Feb-15-24 04:05PM
Jan-10-24 11:30AM
Jan-04-24 09:56AM
Jan-01-24 09:35AM
Dec-27-23 10:45AM
04:30PM
Loading…
Dec-20-23 04:30PM
Dec-19-23 12:13AM
Dec-18-23 04:14PM
Dec-12-23 09:25PM
Dec-11-23 09:35AM
Dec-04-23 03:00PM
08:00AM
Nov-30-23 04:30PM
Nov-28-23 05:55PM
01:44PM
07:24AM
Nov-27-23 09:09PM
04:30PM
Nov-20-23 11:01AM
Nov-16-23 06:42PM
04:11PM
Loading…
04:11PM
Nov-07-23 05:11PM
04:05PM
Nov-06-23 07:00AM
Oct-31-23 04:30PM
Oct-18-23 09:00PM
Oct-03-23 07:00AM
Sep-15-23 05:39PM
Sep-11-23 04:05PM
Sep-06-23 07:00AM
Aug-15-23 07:22PM
Aug-14-23 04:05PM
Aug-07-23 04:30PM
Jul-18-23 07:00AM
Jun-15-23 04:05PM
May-09-23 04:10PM
May-05-23 07:08PM
(The Wall Street Journal)
ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lin Shao-Lee Chief Executive Officer Apr 01 '24 Sale 6.63 9,961 66,024 1,577,374 Apr 03 06:18 PM Lin Shao-Lee Chief Executive Officer Feb 20 '24 Sale 7.60 15,701 119,403 1,587,335 Feb 22 07:04 PM Lin Shao-Lee Chief Executive Officer Jan 02 '24 Sale 7.41 10,691 79,188 1,603,036 Jan 04 06:09 PM Westlake BioPartners Fund II, 10% Owner May 09 '23 Buy 18.00 1,250,000 22,500,000 9,790,729 May 11 09:16 PM SEIDENBERG BETH C Director May 09 '23 Buy 18.00 1,250,000 22,500,000 9,790,729 May 11 09:13 PM SEIDENBERG BETH C Director May 09 '23 Buy 18.00 60,000 1,080,000 60,000 May 11 09:13 PM Gosebruch Henry O Director May 09 '23 Buy 18.00 50,000 900,000 50,000 May 11 09:06 PM Svoronos Dawn Director May 09 '23 Buy 18.00 15,000 270,000 15,000 May 11 09:11 PM Peloso Paul Chief Medical Officer May 09 '23 Buy 18.00 6,000 108,000 6,000 May 11 08:54 PM Dier Mardi CFO and CBO May 09 '23 Buy 18.00 5,556 100,008 5,556 May 11 08:51 PM Kim Mina Chief Legal & Admin. Officer May 09 '23 Buy 18.00 5,000 90,000 5,000 May 11 08:58 PM Becker Daniel J. Director May 09 '23 Buy 18.00 3,000 54,000 3,000 May 11 09:02 PM Dier Mardi CFO and CBO May 09 '23 Buy 18.00 1,750 31,500 875 May 11 08:51 PM Oyston Ronald Chief People Officer May 09 '23 Buy 18.00 1,000 18,000 1,000 May 11 09:00 PM Oyston Ronald Chief People Officer May 09 '23 Buy 18.00 26 468 26 May 11 09:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite